Alcon AG
ALC77.360USD
+2.970+3.99%
종가 11/11, 16:00（ET）시세는 15분 지연됩니다
38.26B시가총액
35.66P/E TTM
자세한 내용은 Alcon AG 회사
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
Alcon AG 정보
종목 코드 ALC
회사 이름Alcon AG
상장일Apr 09, 2019
CEOMr. David J. Endicott
직원 수25599
유형Ordinary Share
회계 연도 종료Apr 09
주소Rue Louis d'Affry 6
도시FRIBOURG
증권 거래소SIX Swiss Exchange
국가Switzerland
우편 번호1700
전화41589113800
웹사이트https://www.alcon.ch/
종목 코드 ALC
상장일Apr 09, 2019
CEOMr. David J. Endicott
Alcon AG의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Ms. Deborah Di Sanzo
Ms. Deborah Di Sanzo
Director
Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
사업별USD
이름
수익
비율
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%
지역별USD
이름
수익
비율
International
1.42B
54.99%
United States
1.16B
45.01%
사업별
지역별
사업별USD
이름
수익
비율
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%
주식 보유 통계
마지막 업데이트: Fri, Aug 15
마지막 업데이트: Fri, Aug 15
주주
주주 유형
주주
주주
비율
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
Aristotle Capital Management, LLC
2.41%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
기타
83.89%
주주
주주
비율
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
Aristotle Capital Management, LLC
2.41%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
기타
83.89%
주주 유형
주주
비율
Investment Advisor
32.72%
Investment Advisor/Hedge Fund
25.40%
Bank and Trust
4.40%
Sovereign Wealth Fund
2.35%
Hedge Fund
2.18%
Research Firm
1.75%
Pension Fund
1.51%
Individual Investor
0.13%
Insurance Company
0.09%
기타
29.47%
기관 주식 보유
마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
1625
347.92M
69.62%
-14.37M
2025Q2
1631
340.08M
68.06%
-38.93M
2025Q1
1659
342.42M
68.52%
-42.21M
2024Q4
1636
370.45M
74.13%
+31.24M
2024Q3
1624
333.39M
66.72%
-2.12M
2024Q2
1594
337.16M
67.47%
-33.61M
2024Q1
1583
337.34M
67.51%
+4.25M
2023Q4
1598
326.79M
65.39%
-10.87M
2023Q3
1582
325.37M
65.11%
-21.48M
2023Q2
1575
329.22M
65.88%
-15.79M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
20.64M
4.13%
+781.14K
+3.93%
Jun 30, 2025
Aristotle Capital Management, LLC
12.04M
2.41%
-191.15K
-1.56%
Jun 30, 2025
UBS Fund Management (Switzerland) AG
11.47M
2.29%
-68.71K
-0.60%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
11.35M
2.27%
-1.28M
-10.12%
Jun 30, 2025
Fidelity Management & Research Company LLC
10.21M
2.04%
-4.82M
-32.06%
Jun 30, 2025
Zürcher Kantonalbank (Asset Management)
9.14M
1.83%
+628.34K
+7.38%
Jun 30, 2025
AKO Capital LLP
7.71M
1.54%
+597.84K
+8.40%
Jun 30, 2025
Harding Loevner LP
7.01M
1.4%
-117.33K
-1.65%
Jun 30, 2025
T. Rowe Price Associates, Inc.
6.98M
1.4%
+2.06M
+41.82%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Thu, Nov 6
마지막 업데이트: Thu, Nov 6
이름
비율
Global X Aging Population ETF
2.3%
Franklin FTSE Switzerland ETF
2.29%
iShares MSCI Switzerland ETF
2.14%
Running Oak Efficient Growth ETF
1.75%
First Trust Indxx Medical Devices ETF
1.6%
Global X S&P Catholic Values Developed ex-US ETF
0.98%
First Trust Switzerland Alphadex Fund
0.68%
iShares Global Healthcare ETF
0.52%
ALPS O'Shares International Developed Quality Dividend ETF
0.48%
Wahed Dow Jones Islamic World ETF
0.44%
더 보기
Global X Aging Population ETF
비율2.3%
Franklin FTSE Switzerland ETF
비율2.29%
iShares MSCI Switzerland ETF
비율2.14%
Running Oak Efficient Growth ETF
비율1.75%
First Trust Indxx Medical Devices ETF
비율1.6%
Global X S&P Catholic Values Developed ex-US ETF
비율0.98%
First Trust Switzerland Alphadex Fund
비율0.68%
iShares Global Healthcare ETF
비율0.52%
ALPS O'Shares International Developed Quality Dividend ETF
비율0.48%
Wahed Dow Jones Islamic World ETF
비율0.44%
주식 배당금
지난 5년 동안 총
400.00M
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
